Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

InSite Vision is committed to advancing new and superior ophthalmologic products for unmet eye care needs. The company's product portfolio utilizes InSite Vision's proven DuraSite(R) bioadhesive polymer core technology, an innovative platform that extends the duration of drug retention on the surface of the eye, thereby reducing frequency of treatment and improving the efficacy of topically delivered drugs. The DuraSite platform is currently leveraged in two commercial products for the treatment of bacterial eye infections, AzaSite(R) (azithromycin ophthalmic solution) 1%, marketed in the U.S. by Inspire Pharmaceuticals, and Besivance(TM) (besifloxacin ophthalmic suspension) 0.6%, marketed by Bausch & Lomb and their partner Pfizer Inc. InSite Vision's clinical-stage ophthalmic product pipeline includes AzaSite Plus(TM) (ISV-502) and ISV-305 for the treatment of eye infections, ISV-303 for pain and swelling associated with ocular surgery, and ISV-101 for the treatment of dry eye disease.

Paik Kwang Industrial Co., Ltd. engages in the production and sale of inorganic chemical products. It operates through the following businesses: Chlor-Akali (CA) Production and Food. The CA Production business manufactures caustic soda, liquid chlorine, synthetic hydrochloride and sodium hypochlorite. The Food business offers sorbitol PS01, PS02 and PS03. The company was founded on November 25, 1954 and is headquartered in Gunsan-si, South Korea.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Telo Therapeutics operates a biotechnology company intended to develop medicine to reverse cancer cell immortality. The company's medicine specializes in inhibiting cancer cell immortality by undergoing the immortalization process, leaving healthy cells intact, enabling patients to get cured of diseases such as cancer.

McLean Hospital was founded on Feb. 25, 1811, through a charter granted by the Massachusetts Legislature for the “Massachusetts General Hospital Corporation.” From its inception, the Corporation intended to treat both physical and mental illnesses, with a separate facility for each. Fundraising campaigns were held between 1812 and 1816, and a majority of the contributors earmarked their donations for the establishment of a facility to treat mental illnesses. McLean Hospital is dedicated to improving the lives of people and families affected by psychiatric illness. McLean Hospital is a comprehensive mental health care facility committed to providing a full range of high quality, cost effective, mental health services. At McLean Hospital, their staff, faculty, volunteers and supporters are dedicated to improving the lives of people and families affected by psychiatric illness. As the largest psychiatric affiliate of Harvard Medical School, McLean has been meeting the needs of individuals and families with psychiatric illness since their founding in 1811. McLean Hospital's staff of more than 1,900 caring and compassionate individuals are each dedicated to improving the lives of people living with mental illness and their families. McLean Hospital is an affiliate of Harvard Medical School and a member of Partners Healthcare. McLean Hospital is the largest psychiatric teaching facility of Harvard Medical School.

Part of Genetron Holdings Ltd., Genetron Health (Beijing) Co., Ltd. is a company headquartered in China. The firm manufactures health management products for cancer clinical treatment.

MicroDiag Biomedicine focuses on the treatment of cancer, Alzheimer's, acute infectious diseases, and other major diseases. The company was founded in 2008 and is headquartered in Suzhou, Jiangsu, China.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Daesang Corp. engages in the food business. It operates through the Food and Ingredient Business segments. The Food Business include general food, ingredients distribution, food research, and center for food safety. The Ingredient Business includes starch and sweetener, bio, lysine, and ingredient research. The company was founded on January 31, 1956 and is headquartered in Seoul, South Korea.

Danisco US, Inc. manufactures synthetic resins, synthetic rubbers and industrial chemicals. The company is headquartered in Wilmington, DE.

New England Biolabs is focused on the discovery and development of recombinant and native enzymes for genomic research. It offers restriction endonucleases for DNA digestion; PCR, polymerases, and amplification technologies for PCR applications; DNA modifying enzymes and cloning technologies; reagents for DNA and RNA sample preparation; DNA, RNA, and protein markers and ladders for electrophoresis applications; reagents for RNA research; and gene expression tools for DNA, RNA, and protein transfection of cell lines. The company also offers cellular analysis solutions; reagents, enzymes, antibodies, and DNA controls for epigenetics research; protein expression and purification technologies; competent cells for transformation and protein expression; protein tools; glycobiology products; and plasmids and DNAs for use in cloning experiments. New England Biolabs was founded in 1974 and is based in Ipswich, Massachusetts.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Beidou Life Sciences (Guangzhou) Co., Ltd., established on 2018-08-03, Business scope includes medical research and experimental development;Natural science research and experimental development;New material technology research and development;Production of protective equipment for medical personnel(Ι class medical device);Manufacturing of medical packaging materials;Production of Class I Medical Devices;Manufacturing of Drug Testing Instruments;drawing,Manufacture of computing and measuring instruments;Wholesale of protective equipment for medical staff;daily mask(non-medical)Sales;Disinfectant sales(Free of Hazardous Chemicals);Sales of special labor protection products;Sales of labor protection products;Sales of Class I Medical Devices;Sales of Class II Medical Devices;software sales;Pharmaceutical special equipment sales;Drug testing equipment sales;Domestic trade agent;sales agent;Sales of daily chemical products;Medical Mask Retail;Sales of hygiene products and single-use medical products;Retailing of protective equipment for healthcare workers;Personal Hygiene Sales;internet sales(Except for products that require a license for sale);Cloud Computing Equipment Sales;Information security equipment sales;Sales of daily chemical products;Internet Security Services;internet data service;Remote Health Management Services;Blockchain technology related software and services;software development;Artificial intelligence application software development;Software outsourcing service;Network and Information Security Software Development;Internet of Things Technology Services;Information Technology Consulting Services;data processing services;Computer System Services;Big data service;Carry out exclusive insurance agency business within the scope authorized by the insurance company(Operate with authorization);Certification Consulting;translation service;Health Consulting Services(Does not include medical services);R&D and application of cell technology;Metering service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology promotion service;R&D and application of cell technology;3Dprint service;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;Professional cleaning,to clean,Disinfection service;Vector biological control services;Medical equipment rental;Special equipment rental;office services;Conference and Exhibition Services;Business agency service;market survey(Does not include foreign investigations);Prevention and control of wild animal epidemics;Vector Biodensity Control Level Evaluation Service;Vector Biodensity Monitoring and Evaluation Service;Science popularization service;Internet of things technology research and development;Pharmaceutical special equipment sales;IoT Device Sales;Disinfectant sales(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Calculator Equipment Sales;Artificial intelligence innovation and innovation service platform;Technology intermediary service;Artificial intelligence public data platform;Artificial intelligence basic software development;Artificial intelligence general application system;Artificial intelligence public service platform technical consulting services;Artificial intelligence basic resources and technology platform;Artificial intelligence industry application system integration service;Network technology service;Artificial intelligence theory and algorithm software development;Research and development of intelligent robots;Digital culture creative software development;Information system operation and maintenance services;pharmaceutical production;Production of Class II Medical Devices;Pharmaceutical commissioned production;Production of hygiene products and single-use medical products;Production of Class III Medical Devices;Production of protective equipment for medical personnel(Class II medical device);Disinfectant production(Free of Hazardous Chemicals);Production of sterile equipment;Production of disinfection products for the prevention and control of infectious diseases;Disinfection equipment sales;Import and export agency;Import and export of edible fungi;Drug Wholesale;Health food sales;Sales of formula food for special medical purposes;Food Internet Sales(Selling prepackaged food);Class III medical device business;Drug retail;Sales of formula food for special medical purposes;Internet Live Streaming Service(Excluding news information service,web show,Internet audiovisual programs);Internet information service;Electronic Authentication Service;Drug internet information service;Internet Information Service for Medical Devices;Call Center;Insurance agency business;Customs clearance;Quality inspection of edible fungi;Inspection and testing service;Special equipment inspection and testing services;Import and export commodity inspection and appraisal;Certification Services;Doping Test;Occupational Health Technical Services;medical service;Internet hospital services relying on physical hospitals;Entry-Exit Quarantine Processing;Special Equipment Design;Quality and safety inspection of agricultural products;Crop Seed Quality Inspection;Safety production inspection and testing;Safety Evaluation Business;Animal Clinic

Suzhou Genowei Biotechnology Co., Ltd., established on 2013-03-12, Business scope includes research and development,Sales:biochemical reagents;Biological Engineering,Biotechnology,Technical development of diagnostic reagent technology,Technical Consulting and Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)